A Randomized, Sham-procedure-controlled, Blinded Study to Evaluate the Effectiveness and Acceptability of Right-sided Stellate Ganglion Block for Treatment of Posttraumatic Stress Disorder Symptoms
Phase of Trial: Phase II
Latest Information Update: 28 Mar 2018
At a glance
- Drugs Ropivacaine (Primary)
- Indications Post-traumatic stress disorders
- Focus Therapeutic Use
- 23 Mar 2018 Planned End Date changed from 30 Nov 2017 to 30 Jun 2018.
- 23 Mar 2018 Planned primary completion date changed from 30 Nov 2017 to 30 Jun 2018.
- 15 Mar 2017 New trial record